|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Trabectedin (Tr) in the treatment of advanced uterine leiomyosarcomas (U- LMS) :Results of a pooled analysis of five single - agent phase Ⅱ studies using the recommended dose显示文摘 | Judson IR Blay J Chawla SP | 2010 | J Clin Oncol2010，28，10： | 1 |
| 2 | Synovial sarcoma: a clinicopathologica, staging, and pr%mostic assessment 显示文摘 | Sphillane AJ A' Hem R Judson IR | 2000 | J Clin Oncol2000，18，： | 1 |
| 3 | Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment 显示文摘 | Spillane AJ A'Hern R Judson IR | 2000 | J Clin Oncol2000，18，22： | 1 |
| 4 | 'Tomudex'(raltitrexed)development:preclinical,phase I and II studies显示文摘 | Judson IR | 1997 | Anticancer Drugs1997，8，2： | 1 |
| 5 | Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice显示文摘 | Orr RM Goddard PM Lacey HA Lancashire H Judson IR | 1997 | J Pharmacol Exp Ther1997，281，1： | 1 |
| 6 | Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children显示文摘 | Verrill MW Judson IR Harmer CL | 1997 | J Clin Oncol1997，15，： | 1 |
| 7 | Trabectedin in the treatment of advanced uterine leiomyo -sarcornas: results of a pooled analysis of five single -agent phase II studies using the recom -mended dose显示文摘 | Judson IR BlayJ Chawla SP | 2010 | J Clin Oncol2010，28，： | 1 |
| 8 | Differential sensitivity of liposarcoma subtypes to chemotherapy显示文摘 | Jones RL Fisher C Al-Muderis O Judson IR | | 0，，18： | 1 |
| 9 | Synovial sarcoma:a clinicopathologic,staging,and prognostic assessment显示文摘 | Spillane AJ AHem R Judson IR | 2000 | J Clin Oncol2000，18，22： | 1 |
| 10 | Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group 显示文摘 | van OOSTEROM AT JUDSON IR VERWEIJ J | 2002 | Eur J Cancer2002，385，： | 1 |
| 11 | Synovialsarcoma:a clinicopathologic,staging,and prognostic assessment显示文摘 | Spillane AJ A'Hern R Judson IR | 2000 | J Clin Oncol2000，18，22： | 1 |
| 12 | Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment 显示文摘 | Spillane AJ A'I-lem R Judson IR | 2000 | J Clin Oncol2000，18，22： | 1 |
| 13 | 'Tomudex' (raltitrexed) development: preclinical, phase I and II studies显示文摘 | Judson IR | 1997 | Anticancer Drugs1997，8，2： | 1 |
| 14 | Synovial sarco-ma:a clinicopathologic,staging,and prognostic assess-ment显示文摘 | Spillane AJ A′Hern R Judson IR | 2000 | J Clin Oncol2000，18，22： | 1 |
| 15 | Synovial sarcoma:a clinico-pathologic,staging,and prognostic assessment显示文摘 | Spillane AJ A'Tiern R Judson IR | 2000 | J Clin Oncol2000，18，22： | 1 |
| 16 | Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors:a report of the EORTC Soft Tissue and Bone Sarcoma Group显示文摘 | Van Oosterom AT Judson IR Verweij J | 2002 | Eur J Cancer2002，38，1： | 1 |
| 17 | Tomudex(raltitrexed) development: preclinical, phase I and II studies显示文摘 | | 1997 | Anti cancer drugs1997，82，： | 1 |
| 18 | Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group显示文摘 | Van Oosterom AT Judson IR Verwej J | 2002 | Eur J Cancer2002，38，5： | 1 |
| 19 | Uterine Sarcoma Dissemination During Myomectomy:if not'acceptable collateral damage,'is it possible to mitigate the risk?显示文摘 | Judson IR Miah AB | 2014 | Cancer2014，120，20： | 1 |
| 20 | Trabectedin (Tr) in the treatment of advanced uterine leiomyosarcomas (U- LMS):Results of a pooled analysis of five single-agent phase Ⅱ studies using the recommended dose显示文摘 | Judson IR Blay J Chawla SP | 2010 | J Clin Oncol2010，28，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员